Au­rinia bounces back, shares soar on pos­i­tive da­ta for lu­pus drug

Last sum­mer, Au­rinia $AUPH found it­self be­tween a rock and a hard place as it sought to ex­plain a trou­bling clus­ter of deaths in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.